Retrieve available abstracts of 9 articles: HTML format
Single Articles
September 2024
WATTS GF, Rosenson RS, Hegele RA, Goldberg IJ, et al Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMoa2409368. PubMedAbstract available
August 2024
FABBRINI E, Rady B, Koshkina A, Jeon JY, et al Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD.
N Engl J Med. 2024;391:475-476. PubMed
May 2024
ROSENSON RS, Gaudet D, Hegele RA, Ballantyne CM, et al Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia.
N Engl J Med. 2024 May 29. doi: 10.1056/NEJMoa2404147. PubMedAbstract available
BALLANTYNE CM, Vasas S, Azizad M, Clifton P, et al Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia.
N Engl J Med. 2024 May 28. doi: 10.1056/NEJMoa2404143. PubMedAbstract available
April 2024
BERGMARK BA, Marston NA, Prohaska TA, Alexander VJ, et al Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2402309. PubMedAbstract available
WATTS GF Shooting the Messenger to Treat Hypertriglyceridemia.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMe2402653. PubMed
STROES ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, et al Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2400201. PubMedAbstract available
February 2024
ALEXANDER VJ, Karwatowska-Prokopczuk E, Prohaska TA, Li L, et al Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.
N Engl J Med. 2024;390:476-477. PubMed
April 2023
ALEXANDER JH Benefits of Bempedoic Acid - Clearer Now.
N Engl J Med. 2023;388:1425-1426. PubMed